You are here: Industry Insights > KEPTIDE

News List

Sotira Completes Pre-Clinical Testing for COVID-19 Vaccine Alternative americanpharmaceuticalreview
December 09, 2020
Sotira has announced the successful completion of the second phase of pre-clinical testing for its COVID-19 therapeutic and vaccine-alternative, KEPTIDE™ COVID, confirming this molecular therapy completely prevented the entry of SARS-CoV2 in the lungs ...
Arizona BioTech Company Successfully Completes Pre-Clinical Testing for Vaccine Alternative to Prevent COVID-19 Infection, Ready for Human Trials prnewswire
November 24, 2020
Sotira, the Phoenix based biotech company, is pleased to announce the successful completion of the second phase of pre-clinical testing for its COVID-19 therapeutic and vaccine-alternative, KEPTIDE™ COVID, confirming that this cutting-edge molecular ...
Sotira Finds Preliminary Success Developing Intranasal COVID-19 Vaccine Alternative americanpharmaceuticalreview
October 29, 2020
Sotira has announced preliminary findings of preclinical safety and efficacy studies for its patent-pending vaccine alternative that has shown in on-going preclinical testing to attenuate COVID-19 infection.